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INTRODUCTION
The most prevalent liver disease in industrialized countries is non-alcoholic fatty liver disease (NAFLD). [1] NAFLD encompasses a spectrum of histological features ranging from simple steatosis to non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis. Development and progression of NAFLD are intricately linked with a number of factors including genetic predisposition, [2, 3] physical inactivity, obesity and insulin resistance (IR). [4, 5] Hepatic steatosis appears to be a prerequisite for more severe liver injury and occurs when the rates of de novo hepatic fatty acid synthesis and of hepatic fatty acid uptake from plasma exceed the rate of hepatic fat oxidation and triglyceride (TG) export. [6] There is evidence that patients with NAFLD have increased free fatty acid delivery from the adipose tissue, [7] increased de novo hepatic fatty acid synthesis [8] and increased TG export. [9] On the other hand, it is less clear whether patients with NAFLD have altered whole-body and hepatic fat oxidation (Fat ox ).
An ideal cadre to study whole-body substrate metabolism is to assess substrate oxidation rates under a number of physiological conditions including the basal state (resting and fasting conditions), after a meal or insulin stimulation and during exercise. [10] Studies investigating whole-body substrate oxidation of NAFLD patients in the basal state have reported conflicting results. Perseghin et al. [11] found lower rates of whole-body Fat ox in obese adolescents with NAFLD compared to counterparts without fatty liver. In contrast, Bugianesi et al. [12] reported a tendency for higher rates of whole-body Fat ox in 12 non-obese patients with NAFLD when compared with 6 body mass index (BMI)-matched controls. Similarly, Sanyal et al. [13] found higher Fat ox in 6 obese NAFLD compared to 6 obese NASH, although both NAFLD and NASH groups did not differ from 6 lean controls. Krotonen et al. [14] found no significant difference between 29 moderately overweight individuals with NAFLD and 29 leaner healthy control. In the latter group of studies [12, 13, 14] between-group differences in hepatic Fat ox mirrored those for whole-body Fat ox . In the insulin-stimulated state, results are more uniform with NAFLD patients showing a reduced insulin-mediated suppression of Fat ox compared to controls. [11, 12, 14] To date, substrate oxidation during exercise has not been compared between patients with NAFLD and counterparts without fatty liver. It is important to better understand substrate metabolism during exercise because whole-body metabolic demands are increased and potential abnomalities not seen in the resting state may become apparent. Further, exercise training is increasingly recommended clinically as a component of lifesyle interventions. [15, 16] Differences in severity of liver disease in previous cohorts may have contributed to the contrasting results reported on basal substrate metabolism in NAFLD. However, the relationship between severity of disease (which can only be assessed by liver histology) and substrate oxidation under various metabolic conditions has not been investigated to date in adults with NAFLD. In obese adolescents with NAFLD, hepatic steatosis (measured by magnetic resonance spectroscopy) and impairment in basal whole-body Fat ox were shown to be positively correlated, independent of BMI. [11] The objective of this study was to measure substrate utilization under basal, insulin-stimulated and exercise conditions in adult patients with NAFLD and to explore whether these outcome measures were correlated with degree of steatosis and severity of liver disease.
METHODS

Participants
Twenty overweight/obese patients with NAFLD and 15 lean healthy controls participated in the study. Patients were recruited from outpatient hospital clinics and NAFLD was diagnosed clinically and on liver biopsy. Exclusion criteria included the presence of other causes of liver disease (serologically and on history), evidence of cirrhosis or decompensated liver disease, alcohol consumption >40 g/day in males or >20 g/day in females (assessed by detailed clinical history) and type 2 diabetes. Control participants were healthy non-obese adults with: normal liver enzymes (alanine transaminase <35 U/L; aspartate aminotransferase <35 U/L), no evidence of liver disease (serologically and on history), no hepatomegaly on clinical examination and no features of the metabolic syndrome. [17] Controls were non-smoking, not taking regular medications and had minimal alcohol intake. In individuals meeting these same criteria, the prevalence of steatosis has been shown to be 5% [18] or lower. [19] The study was approved by the Human Research Ethics Committees of the Princess Alexandra Hospital and the University of Queensland. Informed written consent was obtained from all participants.
While we considered the benefit of an additional obese non-NAFLD control group, the prospective liver biopsy of control participants for the purpose of this study was deemed unethical by the ethics committee and therefore exclusion of NAFLD in an obese control was not possible for this study. Further, it could be argued that obese individuals without steatosis are metabolically atypical [20] and therefore not an appropriate control group. Instead, it has been proposed that healthier physically active individuals should be assigned as a control group. [21] Accordingly, this study compares measurements in NAFLD to a healthy reference and then further explores study aims regarding disease severity within the NAFLD group alone.
General design
Each participant undertook testing in the morning after a 10-12 hour overnight fast on two occasions within a 7-day period. The first testing session involved a hyperinsulinemiceuglycemic clamp with indirect calorimetry measurements to assess substrate oxidation rates in two conditions: basal (in resting and fasted conditions) and insulin-stimulated (during the steady state of a hyperinsulinemic-euglycemic clamp). The second testing session involved indirect calorimetry measurement during a graded exercise test on a cycle ergometer to assess substrate oxidation rate and   VO 2max (aerobic fitness).
Histological analysis of liver biopsy
Liver biopsy specimens were fixed in 10% neutral buffered formalin, embedded in paraffin, and were subsequently scored by an expert hepatopathologist (AC). The percentage of hepatocytes with steatosis was estimated. The severity of liver injury was assessed using the NAFLD activity score (NAS) [22] 
Hyperinsulinemic-euglycemic clamp
Insulin sensitivity was evaluated by the hyperinsulinemic-euglycemic clamp technique, [26] with a protocol previously described. [12] Teflon catheters were placed into an antecubital vein for infusions, and into a dorsal hand vein (heated to 55C to achieve arterialization of venous blood) for sampling. After obtaining a basal blood sample, primed insulin infusion was initiated at a rate of 1 mUkg 
Biochemical analysis
Blood samples were drawn at 10-minute intervals during the last 40 minutes of the hyperinsulinemic-euglycemic clamp. Glucose was analyzed using an automated glucose analyzer interassay coefficient of variation (CV) 2%. Insulin was assayed using an 
3%). Plasma β-hydroxybutyrate
concentrations, an index of hepatic ketogenesis, [29] were measured enzymatically (Stanbio, Boerne, TX, CV 2.2%).
Graded exercise test
Maximal aerobic power and substrate utilization were assessed with a graded exercise test on a cycle ergometer. Testing included a sub-maximal phase to assess energy expenditure, Fat ox and CHO ox at various intensities, and a maximal phase to determine peak oxygen consumption (   VO 2 peak ). The starting workload for the submaximal phase was individualized at 20% of the theoretical maximal mechanical work. [30] Workload was increased by 10% at each stage until the respiratory exchange ratio was above 1.0 during the last minute of the stage. Stages lasted 5 minutes and were separated by 2-minute rest intervals. The maximal phase started at a workload corresponding to two stages below the intensity reached at the end of the submaximal phase, and workload was incremented by 10% every minute until volitional exhaustion.
Indirect calorimetry
Indirect calorimetry measurements (TrueOne 2400 Metabolic Measurement System, Parvo
Medics, UT) to determine oxygen consumption (  VO 2 ) and carbon dioxide production (   VCO 2 )
were performed in three conditions: 1) basal, 2) insulin-stimulated and 3) exercise. Basal and insulin-stimulated measurements lasted 20 minutes with participants lying supine and breathing through a ventilated hood. Measurements during the graded exercise test were performed continuously, with participants wearing mouthpiece and nose clip. 
RESULTS
Participant characteristics
Characteristics of study groups are presented in Table 1 . Liver histology from patients with NAFLD showed macrovesicular steatosis ranging from 10 to 100%, with an average of 7131%. Sixteen patients were diagnosed with NASH, while four with steatosis alone.
Fourteen patients had a NAS5, while six patients had a NAS<5. Fibrosis was observed in 10 
Insulin resistance
Patients with NAFLD were severely insulin resistant ( Figure 1A and 1B). This was confirmed by the higher RQ in patients with NAFLD (0.820.04 vs. 0.780.03, P=0.007, Figure 1C ).
Within the overweight/obese NAFLD group, basal RQ was positively correlated with hepatic steatosis (r=0.57, P=0.01, Figure 2A Figure 2B 
P<0.001).
Substrate oxidation under insulin-stimulated conditions
Under insulin-stimulated conditions there was no apparent difference between groups in total energy expenditure (P=0.27). However, patients with NAFLD had lower CHO ox (P=0.036, Figure 1C ) and a lower RQ (P=0.037, Figure 1C Figure 1D ). Consistently, the change in RQ from the basal state was smaller in NAFLD (0.040.03 vs. 0.110.04, P<0.001, Figure 1C ). Hepatic steatosis was not correlated with change in RQ from basal to insulin-stimulated conditions (P=0.29), however there was a trend for the % hepatic steatosis to be correlated with the insulin sensitivity index (r=-0.40, All the results of this study were confirmed by covariate analysis, with FFM as covariate.
P=0.09).
Substrate oxidation during exercise
DISCUSSION
In NAFLD, hepatic steatosis is intricately linked with a number of metabolic alterations. In the current study, overweight/obese patients with NAFLD demonstrated reduced whole-body Fat ox in basal conditions and during acute exercise compared to lean controls. Within the overweight/obese NAFLD group, alterations in basal substrate metabolism were associated with more severe steatosis and more severe disease, independent of BMI and fat topography.
Patients with NAFLD also had reduced basal hepatic Fat ox , and this was associated with increased fasting circulating TG.
The present study was designed to comprehensively investigate substrate metabolism and IR.
It is the largest study to assess disease severity by liver histology in conjunction with wholebody substrate metabolism and IR. Substrate oxidation was measured in three different physiological states: basal, insulin-stimulated and exercise, which forms an ideal cadre to study whole-body energy homeostasis and understand mechanisms of dysfunction. Gold standard techniques for the assessment of liver disease (liver histology), IR (hyperinsulinemic-euglycemic clamp) and body composition (dual-energy X-ray absorptiometry) were used. NAFLD patients with a broad spectrum of steatosis were studied (10-100%).
In the patient group studied, NAFLD and obesity coexisted, therefore it was not possible to establish the specific contribution of each factor to the differences observed between patients and lean controls. For this reason, we did not limit our study to a comparison between NAFLD and controls, but also performed analyses within the overweight/obese NAFLD cohort, to establish the relationship between disease severity and substrate oxidation under different physiological conditions.
In basal conditions, patients with NAFLD demonstrated an alteration in whole-body substrate metabolism with a lower Fat ox and a higher CHO ox compared to controls. The different outcome compared to previous studies (which showed Fat ox to be lower, [11] similar, [14] or trending to be higher [12] in NAFLD versus controls) could be due to the heterogeneity of disease severity in NAFLD or to differences in plasma substrate concentrations such as fasting glucose and fasting FFA. Anthropometric characteristics of the study groups may also be implicated. Some studies have attempted to match groups for BMI by comparing lean [11] or moderately overweight individuals [14] with and without NAFLD. While this approach has some advantages, it also has limitations. Lean individuals with NAFLD represent only a small proportion of the clinical population [18, 19] and may have different genetic characteristics. [2] In additon, BMI is a poor indicator of body composition and body fat distribution at the individual level. [33] To determine if there was a dose effect between the severity of steatosis and basal substrate metabolism we performed analyses within the overweight/obese NAFLD cohort. We found that hepatic steatosis was positively correlated to basal RQ and that RQ was significantly higher in patients with more severe disease. A higher basal RQ indicates that a smaller proportion of whole-body total energy expenditure is derived from Fat ox . These findings were independent of visceral adipose tissue, % body fat and BMI. These observations suggest that reduced whole-body Fat ox in basal conditions may contribute to hepatic fat accumulation and may be implicated in the pathogenesis of NAFLD. Accordingly, a recent review proposed that alterations in fatty acid metabolism lead to an accumulation of ectopic (intrahepatic and intramuscular) TG, resulting in IR in liver and skeletal muscle. [6] In addition to lower basal rates of whole-body Fat ox , the patients with NAFLD we studied had lower basal concentrations of -hydroxybutyrate, indicating reduced hepatic Fat ox . [29] The lower basal -hydroxybutyrate in NAFLD despite similar basal FFA concentrations for both NAFLD and control suggests differential fatty acid partitioning in the liver between groups.
[34] Indeed, very low-density lipoprotein (a product of the esterification pathway) was higher in NAFLD while -hydroxybutyrate (a product of the oxidative pathway) was lower.
Basal -hydroxybutyrate was negatively correlated with very low-density lipoprotein and TG, both when combining groups and when performing the analysis within the NAFLD cohort. In animal models, an inhibition of hepatic Fat ox leads to an increase in hepatic steatosis, [35, 36] while an increase in hepatic Fat ox reduces hepatic steatosis. [37, 38] In humans, lower basal -hydroxybutyrate concentrations were found in obese compared with lean individuals [39, 40] and in hypertriglyceridaemic compared with normolipidaemic moderately obese individuals. [41] Few studies have examined this issue in NAFLD, and results are inconsistent, with either higher [12] or similar [13, 14] -hydroxybutyrate concentrations in NAFLD vs.
controls. In these studies the differences in hepatic Fat ox between patients and controls mirror those for fasting FFA. [12, 13, 14] When studying substrate oxidation in insulin-stimulated conditions, we noted that patients with NAFLD increased CHO ox and suppressed Fat ox to a lesser extent than controls, and this was consistent with previous observations. [11, 12, 14] In other words, patients demonstrated metabolic inflexibility, which was defined by Kelley et al. as an impaired capacity to adapt fuel oxidation to fuel availability. [42] Assessment of IR revealed that the patients with NAFLD had lower M-value and lower oxidative and non-oxidative glucose disposals compared to the control group, indicating a global impairment in skeletal muscle glucose metabolism. Between-group differences in insulin sensitivity were even more apparent after normalizing for the insulin concentrations achieved. We acknowledge that M-value and nonoxidative glucose disposal rate may be underestimated in this study given that the hepatic glucose output was not considered, however, previous research has shown that with the insulin dosage that was used in the present study, hepatic glucose output is minimal even in obese [13] or NAFLD patients. [12] Further, consistent with previous observations, we showed that patients with NAFLD had more severe IR in the adipose tissue than controls [12, 43] and that severity of adipo-IR was related to the severity of hepatic fibrosis. [44, 45] Another finding of the present study was that, during exercise, MFO in patients with NAFLD was less than half those in control participants, indicating a reduced ability to increase fat oxidation when performing an acute exercise session. However, the lower aerobic fitness appeared to contribute to the lower MFO observed in patients with NAFLD. After correcting for   VO 2 peak , the difference in MFO between NAFLD and control was no longer apparent. We also observed that the aerobic fitness of patients with NAFLD was extremely low, with most patients falling in the lowest percentile according to the American College of Sports Medicine guidelines. [51] Low fitness level [52] and NAFLD [53] have been shown to be independently associated with the risk of cardiovascular events, however, few studies have assessed physical fitness quantitatively in NAFLD.
Longitudinal studies demonstrate that lifestyle interventions aimed at increasing aerobic fitness improve IR, [54] and positively impact on Fat ox under basal [55] and exercise [16, 56] conditions. A recent study showed that the magnitude of reduction in steatosis after calorie restriction was negatively correlated with post-treatment plasma ketone body and negatively correlated with post-treatment basal RQ, [57] suggesting that enhanced hepatic and wholebody Fat ox contribute to the reduction in steatosis. Therefore, approaches that enhance basal and exercise Fat ox may have a role in the management of NAFLD. These include exercise training, [55] calorie restriction, [57] but also some pharmacological [58] and nutraceuticals agents. [59] In conclusion, this study showed that overweight/obese patients with NAFLD have reduced 
